ORGANOGENESIS HOLDINGS INC.

Analyst Reco. Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
3.03 ^USD	+32.89%		+21.69%	-25.92%

05-10	Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup	DJ
05-09	Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BTIG Raises Price Target on Organogenesis Holdings to $6 From $4, Keeps Buy Rating	12-27	MT
Morgan Stanley Adjusts Price Target on Organogenesis to $3.50 From $3, Maintains Equalweight Rating	11-14	MT
Hopes of rate peak, China turnaround lift stocks	04/09/23	AN
Morgan Stanley Adjusts Price Target on Organogenesis Holdings to $3 From $5, Maintains Equal-Weight Rating	11/08/23	MT
Morgan Stanley Starts Organogenesis Holdings at Equalweight With $5 Price Target	15/06/23	MT
BTIG Upgrades Organogenesis to Buy From Neutral, Price Target is $10	24/05/23	MT
BTIG Downgrades Organogenesis Holdings to Neutral From Buy	10/11/22	MT
Oppenheimer Downgrades Organogenesis Holdings to Perform From Outperform, Removes $14 Price Target	10/08/22	MT
SVB Leerink Adjusts Organogenesis Holdings' Price Target to $20 from $26, Keeps Outperform Rating	10/11/21	MT
ORGANOGENESIS : Oppenheimer Adjusts Organogenesis Holdings PT to $28 From $25 on Strong Q1 Beat and Raised Guidance, Maintains Outperform Rating	11/05/21	MT
ORGANOGENESIS : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $25 From $21, Keeps Outperform Rating	21/04/21	MT
ORGANOGENESIS : SVB Leerink Adjusts Price Target on Organogenesis Holdings to $22 From $19, Maintains Outperform Rating	17/03/21	MT
ORGANOGENESIS : Credit Suisse Raises Organogenesis Holdings' PT to $21 from $9, Expects Continued Success of Commercial Execution Strategy; Keeps Outperform Rating	12/03/21	MT
ORGANOGENESIS : SVB Leerink Adjusts Organogenesis Holdings' Price Target to $13 From $10, Keeps at Outperform	20/01/21	MT
ORGANOGENESIS : Oppenheimer Adjusts Price Target on Organogenesis Holdings to $13 From $9, Maintains Outperform Rating	15/01/21	MT
ORGANOGENESIS : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $9 from $8, Keeps Outperform Rating	07/01/21	MT
ORGANOGENESIS : SVB Leerink Adjusts Organogenesis Holdings' Price Target to $10 From $9, Keeps at Outperform	18/11/20	MT
ORGANOGENESIS : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $8 from $7, Keeps Outperform Rating	10/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer